Mary Elizabeth Bollinger1, Arlene Butz2, Mona Tsoukleris3, Cassia Lewis-Land2, Shawna Mudd4, Tricia Morphew5. 1. Division of Pediatric Pulmonary and Allergy, University of Maryland School of Medicine, Baltimore, Maryland. Electronic address: mbolling@som.umaryland.edu. 2. Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland. 3. University of Maryland School of Pharmacy, Baltimore, Maryland. 4. Department of Acute and Chronic Care, School of Nursing, University of Maryland, Baltimore, Maryland. 5. Morphew Consulting LLC, Bothell, Washington.
Abstract
BACKGROUND:Intensive care unit (ICU) admission is a risk factor for fatal asthma. Little is known about risk factors for pediatric ICU admissions for asthma. OBJECTIVE: To examine characteristics of underserved minority children with prior ICU admissions for asthma. METHODS:Baseline survey data, salivary cotinine levels, and allergen specific IgE serologic test results were obtained from children with uncontrolled asthma enrolled in a randomized clinical trial of a behavioral education environmental control intervention. Characteristics of children with and without prior ICU admission were compared using χ2 and t tests. Logistic regression assessed significance of higher odds of prior ICU admission comparing factor-level categories. RESULTS:Patients included 222 primarily African American (93.7%), male (56%), Medicaid-insured (92.8%) children with a mean (SD) age of 6.4 (2.7) years with uncontrolled asthma. Most (57.9%) had detectable cotinine levels, 82.6% were sensitized to more than 1 environmental allergen, and 27.9% had prior ICU admissions. Prior ICU patients were more likely to be very poor (<$10,000 per year) and sensitized to more than 1 allergen tested (most importantly mouse) (P < .05). Allergen sensitization in the groups did not differ for cockroach, cat, dog, Alternaria, Aspergillus, dust mite, grass, or tree. Although more ICU patients received combination controller therapy, they also overused albuterol. Only 27.4% of ICU patients received specialty care in the previous 2 years, which was not significantly different from non-ICU patients. CONCLUSION:Children with high mortality risk, including history of ICU admission, were twice as likely to live in extreme poverty, have atopy (particularly mouse allergen), use combination controller therapy, and overuse albuterol. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01981564.
RCT Entities:
BACKGROUND: Intensive care unit (ICU) admission is a risk factor for fatal asthma. Little is known about risk factors for pediatric ICU admissions for asthma. OBJECTIVE: To examine characteristics of underserved minority children with prior ICU admissions for asthma. METHODS: Baseline survey data, salivary cotinine levels, and allergen specific IgE serologic test results were obtained from children with uncontrolled asthma enrolled in a randomized clinical trial of a behavioral education environmental control intervention. Characteristics of children with and without prior ICU admission were compared using χ2 and t tests. Logistic regression assessed significance of higher odds of prior ICU admission comparing factor-level categories. RESULTS:Patients included 222 primarily African American (93.7%), male (56%), Medicaid-insured (92.8%) children with a mean (SD) age of 6.4 (2.7) years with uncontrolled asthma. Most (57.9%) had detectable cotinine levels, 82.6% were sensitized to more than 1 environmental allergen, and 27.9% had prior ICU admissions. Prior ICU patients were more likely to be very poor (<$10,000 per year) and sensitized to more than 1 allergen tested (most importantly mouse) (P < .05). Allergen sensitization in the groups did not differ for cockroach, cat, dog, Alternaria, Aspergillus, dust mite, grass, or tree. Although more ICU patients received combination controller therapy, they also overused albuterol. Only 27.4% of ICU patients received specialty care in the previous 2 years, which was not significantly different from non-ICU patients. CONCLUSION:Children with high mortality risk, including history of ICU admission, were twice as likely to live in extreme poverty, have atopy (particularly mouse allergen), use combination controller therapy, and overuse albuterol. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01981564.
Authors: Wanda Phipatanakul; Augusto A Litonjua; Thomas A E Platts-Mills; Lisa M Naccara; Juan C Celedón; Hassen Abdulkerim; Elaine B Hoffman; Diane R Gold Journal: J Allergy Clin Immunol Date: 2007-06-25 Impact factor: 10.793
Authors: Anna B Fishbein; Todd A Lee; Miao Cai; Sam S Oh; Celeste Eng; Donglei Hu; Scott Huntsman; Harold J Farber; Denise Serebrisky; Jonathan Silverberg; L Keoki Williams; Max A Seibold; Saunak Sen; Luisa N Borrell; Pedro Avila; William Rodriguez-Cintron; Jose R Rodriguez-Santana; Esteban G Burchard; Rajesh Kumar Journal: Ann Allergy Asthma Immunol Date: 2016-05-27 Impact factor: 6.347
Authors: Michael Schatz; Robert S Zeiger; William M Vollmer; David Mosen; Guillermo Mendoza; Andrea J Apter; Thomas B Stibolt; Albin Leong; Michael S Johnson; E Francis Cook Journal: Chest Date: 2006-07 Impact factor: 9.410
Authors: S Suissa; P Ernst; J F Boivin; R I Horwitz; B Habbick; D Cockroft; L Blais; M McNutt; A S Buist; W O Spitzer Journal: Am J Respir Crit Care Med Date: 1994-03 Impact factor: 21.405
Authors: Nicholas A Jabre; Corinne A Keet; Meredith McCormack; Roger Peng; Susan Balcer-Whaley; Elizabeth C Matsui Journal: J Community Health Date: 2020-10